What about antibiotics for the treatment of the dyskinesia induced by L-DOPA?
Elaine Del-Bel · Professor of Physiology,Department of Morphology, Physiology and Basic Pathology, School of Dentistry, Ribeirão Preto (FORP), University of São Paulo.
6-hydroxydopamine
18 items · last seminar 14 Dec 2020
18 results
Newest first
Seminar1
2020
ePosters17
FENS 2024
Assessing the therapeutic impact of a 7-day N-acetylcysteine treatment in a preclinical model of Parkinson's disease: Behavioral and molecular insights
Rita Caridade, Bruna Araújo, Ana Catarina Vilaça-Ferreira et al.
Behavior and cellular alterations in a pre-clinical model of Parkinson’s disease with abrogated adult hippocampal cytogenesis
Bruna Araújo, Rita Caridade-Silva, Ana Catarina Vilaça-Ferreira et al.
Characterisation of the neuroprotective effects of the new metabotropic glutamate receptor 3 positive allosteric modulator against dopaminergic degeneration in Parkinson’s disease models
Giulia Urone, Monica Frinchi, Miriana Scordino et al.
Show 14 more from FENS Forum 2024
Identification of the striatal molecular landscape in Parkinson’s disease mouse models
Marta Graziano, Ioannis Mantas, Yuvarani Masarapu et al.
Identifying candidate genes associated with hippocampal dysfunction in a hemiparkinsonian rat model by transcriptomic profiling
Bohye Kim, Sungmoo Hong, Jeongmin Lee et al.
Lesions of the lateral hypothalamus-nigral projection result in motor deficits in rats: Implications for Parkinson’s disease
Asena Bingul, Sam Merlin, Simon Killcross, Teri Furlong
Movement-related dopamine signaling in mouse dorsal striatum in health and parkinsonism
Guy Yona, David Bergin, Calum Mulveen et al.
Olfactory dysfunction as a common denominator in multiple sclerosis and Parkinson’s disease – Evidence from animal models
Andjela Stekic, Milorad Dragic, Milica Zeljkovic Jovanovic, Nadezda Nedeljkovic
P2Y1 receptor participates in dopaminergic neurodegeneration in a rat model of Parkinson’s disease
Roberta Andrejew, Ágatha Oliveira-Giacomelli, Juliana Baranova et al.
Paraquat and 6-hydroxydopamine modulate nucleotide and nucleoside catabolism in zebrafish
Carla Denise Bonan, Josiane Woutheres Bortolotto, Stefani Altenhofen et al.
Pathology of the subthalamic nucleus in Parkinson’s disease
Asheeta Prasad, Teri Furlong, Disni Bandaranayake
Pharmacological and RNAi-mediated inhibition of class-IIa HDACs both protect against dopaminergic neuronal degeneration in in vivo models of Parkinson’s disease
Adam O'Mahony, Martina Mazzocchi, Louise Collins et al.
Role of the medial prefrontal cortex, striatum, and nucleus accumbens in the emission of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats treated with dopaminergic drugs
Jacopo Marongiu, Giulia Costa, Nicola Simola, Marcello Serra
Severity assessment in the unilateral and bilateral 6-OHDA rat Parkinson model: Telemetric monitoring of heart rate and activity
Marcel Roland Oelerich, Ann-Kristin Riedesel, Mesbah Alam et al.
Synthesis, molecular docking and motor function assessment of a novel diaryl pyrrole compound following the unilateral 6-hydroxydopamine lesion model in male rats
Elaheh HaghaniSamani, Anahita Torkaman-Boutorabi, Mona Salimi et al.